(Toronto, Ontario, March 1, 2017) The Empire Life Insurance Company (Empire Life) (TSX: EML.PR.A.) announced today it will make its specialty drug program a standard feature in all Group drug plans it offers. The specialty drug program, part of the Empire Life Actively Managed Drug Solutions portfolio, will be included in new customers’ plans starting June 1, 2017. Current customers will join the program when their policies renew.
(Kingston, ON – February 24, 2017) – The Empire Life Insurance Company (Empire Life) (TSX: EML.PR.A) has declared a cash dividend on the Non-Cumulative Rate Reset Preferred Shares, Series 1, being $0.359375 per share to be paid on April 17, 2017 to shareholders of record March 17, 2017.